Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice
Published in Nature on June 29th, 2023
In new research on Covid-19 vaccines, MCIDT affiliate Dr. Pamela Wong and Dr. Michael Schotsaert of Icahn School of Medicine developed an intranasal vaccine that induces a more robust mucosal immune response than injectable vaccines and long-lasting immune responses among young and aged mice!
http://rb.gy/ljjd2